ETHK Labs Overhauls Board, Committees and Company Secretary After Senior Resignations

IVD Medical Holding Limited ( (HK:1931) ) has shared an announcement.

ETHK Labs Inc. has announced substantial changes to its leadership and governance structure effective 13 January 2026, with the resignation of executive directors Mr. Law Kim Fai and Ms. Tai Yang, and independent non-executive director Mr. Wong Sze Lok, alongside Mr. Law stepping down as chief financial officer, company secretary and authorised representative. In response, the company has reshuffled key board committees, appointing Mr. Zhang Jianlei as chairman of both the audit and remuneration committees, adding Mr. Chan Siu Kei Ken to the nomination committee and naming him company secretary, and appointing Mr. Zhong Renqian and Mr. Xu Da to the remuneration committee. The changes leave the nomination committee temporarily without gender diversity as required under Hong Kong’s corporate governance code, and the board has indicated it will review the committee’s composition, underscoring ongoing governance obligations and the importance of maintaining regulatory compliance amid senior management turnover.

The most recent analyst rating on (HK:1931) stock is a Hold with a HK$2.50 price target. To see the full list of analyst forecasts on IVD Medical Holding Limited stock, see the HK:1931 Stock Forecast page.

More about IVD Medical Holding Limited

ETHK Labs Inc., incorporated in the Cayman Islands and listed in Hong Kong, is part of a group engaged in business activities that require a formal board, audit, remuneration and nomination committee structure under Hong Kong’s Listing Rules and Corporate Governance Code, indicating a regulated, exchange-listed corporate profile focused on compliance and governance standards.

Average Trading Volume: 2,707,640

Technical Sentiment Signal: Sell

Current Market Cap: HK$3.78B

See more insights into 1931 stock on TipRanks’ Stock Analysis page.